Robotis is a component maker that produces actuators, the equivalent of a robot's joint motors. Its flagship DYNAMIXEL X-series accounts for about 90% of revenue, and the actuator business overall is around 98%; starting in research and education, its uses have widened into aerospace, medical, and entertainment, and recently humanoid components, with a high export share (about 40% domestic and about 32% U.S.). It spun off its loss-making autonomous indoor-delivery robot business as of June 1, 2026, so the parent now concentrates on the profitable actuator business. In the first quarter, about ₩11.8 billion was booked as expense from granting treasury shares for performance rewards, making the surface look loss-making, but this is a non-recurring item, and in May the exchange ran investment-warning/caution procedures. What stands out lately is that, on a structural trend where more humanoids mean greater actuator demand, its long-built technology, broad customer base, and near-net-cash balance sheet have grown revenue for a third straight year and turned it to profit; still, the core margin is thin and the R&D burden is heavy (about 80% of first-quarter revenue), so how fast the revenue target and orders actually harden into profit is the crux.
At-a-glance assessment financial health · growth · profitability · valuation
- Revenue rose 29.6% year over year, and the pace is quickening (3-year trend: rising).
- Net profit swung from a loss a year earlier back into the black (a turnaround).
- Most recent quarter (Q1 2026) revenue was 15.8% higher than a year earlier.
- ROE is 1.6% (controlling-interest basis). It is above the sector average.
- Operating margin is 8.6%.
- The P/E sits above the sector median, reflecting elevated expectations.
Ownership & governance As of 2025-12-31
Largest shareholder Kim Byoung-soo 24.1% (individual)
Controlling bloc incl. related parties 24.2%
With the controlling bloc holding 24%, control is maintained but the free float is relatively large.
🔎 In-depth analysis
- Robotis is a component maker that produces and sells actuators, the equivalent of a robot's 'joint motors.' Its flagship DYNAMIXEL X-series accounts for about 90% of revenue, and the actuator business overall makes up around 98% of revenue.
- Starting in research and education, its uses have now widened into aerospace, medical, and entertainment, and more recently into humanoid (human-shaped robot) components.
- By region, exports are a large share: about 40% domestic, about 32% U.S., and about 12% China.
- The loss-making autonomous indoor-delivery robot business was spun off into a separate subsidiary as of June 1, 2026, so the parent now concentrates on the profitable actuator business.
- The latest close is ₩204,000 and the market cap is ₩3.0 trillion.
- The price sits below both its 20-day moving average (₩260,695) and its 60-day line (₩292,207).
- Trading below both the short- and medium-term moving averages, the trend is on the subdued side.
- The RSI (a gauge that scores upward versus downward momentum over the past 14 days on a 0-100 scale) is 34.8, a neutral reading.
- The stock is down 25.7% over one month and 12.4% over three months, and it stands 49.6% below its 52-week high.
- Its relative strength versus the KOSDAQ is 89 (on a 1-99 scale that converts one-year return against the index, weighting recent performance more heavily; higher means stronger than the market), placing it in roughly the top 10% by strength across all stocks.
- Over the past three months it has edged out the index by 9.4%.
- Chart signals are best read alongside trading volume and disclosure dates.
- On a 2025 consolidated basis, revenue was ₩38.9 billion, operating profit ₩3.35 billion, and net profit ₩5.07 billion, the first year of turning to profit after long losses.
- That net profit (₩5.07 billion) exceeds operating profit (₩3.35 billion) because non-operating gains (from financial assets held, among others) were added, so on core strength alone the base is still thin.
- The P/E prints very high at 589.25x, but that reflects dividing by the small profit of the first year in the black, so it is hard to cite as evidence that the stock is 'expensive.' The P/B is 9.56x and ROE (how much is earned on equity in a year) is 1.6%, so profitability is still in the early stage of recovery.
- The balance sheet is very solid, with current assets of ₩247.8 billion against current liabilities of ₩5.4 billion (a current ratio of 4,579%), giving large short-term liquidity.
- The debt ratio (debt relative to equity) is 102%, but most is not interest-bearing borrowing, so it is a near-net-cash structure.
- Revenue rose steadily from ₩22.4 billion in 2021 to ₩29.1 billion in 2023 to ₩38.9 billion in 2025, and 2025 accelerated to +29.6% year over year (a third straight year of increase).
- Operating profit turned positive at +₩3.35 billion in 2025 from -₩5.3 billion in 2023 and -₩3.0 billion in 2024, and net profit turned positive the same year.
- First-quarter 2026 revenue was ₩11.8 billion, up 15.8% year over year.
- The first-quarter operating loss of -₩11.8 billion, by contrast, was not deteriorating performance but a non-recurring, non-cash cost, as about ₩11.8 billion of treasury shares granted to executives and staff for performance rewards in January was booked at once in selling and administrative expenses.
- Stripping out this cost, the core business was roughly around breakeven.
- The picture ahead is humanoid demand.
- The company sees actuator orders rising from around 400,000 units in 2025 to more than 1 million in 2026, and a large plant in Uzbekistan (annual capacity of 5 million units) built with a ₩60 billion investment is set for partial operation in October this year.
- The company has set targets of ₩50 billion in revenue this year (about +29% year over year) and ₩100 billion next year.
- There is no confirmed basis for next year's outlook being lower than this year's, so it is not yet a stage to view the present as a growth peak.
- Recent developments fall into three strands.
- First is the spin-off that underpins the growth blueprint.
- Carving the loss-making autonomous indoor-delivery robot business out into a subsidiary as of June 1, 2026 lets the parent concentrate on the profitable actuator business.
- Second is the treasury-share performance grant that left a large mark on first-quarter accounting.
- Granting treasury shares to executives and staff as compensation booked about ₩11.8 billion as first-quarter expense, making the surface result look loss-making, but this is a non-recurring item.
- Third are signals related to price overheating.
- Citing an unusually large excess price gain over the past year, the Korea Exchange in May 2026 ran procedures to pre-designate the stock as an investment-warning name and to designate it as an investment-caution name, which is a market caution signal about the speed of the price gain rather than about results.
- The strong side is clear.
- As more humanoids appear, demand for the joint-motor actuator grows, and Robotis holds long-built technology and a broad customer base in this component (from research and education to overseas humanoid firms).
- Revenue has grown for a third straight year and turned to profit, and the strategy to widen share with the large Uzbekistan plant and a volume-oriented Q-series has a clear direction.
- The balance sheet is near net cash, giving ample investment capacity.
- The cautious side is equally clear.
- The core margin is still thin and the R&D burden is heavy (first-quarter R&D was about 80% of revenue).
- The Q-series is a volume-over-margin strategy, so it is hard to assume profit rises in proportion as revenue grows.
- The high surface P/E and P/B owe much to the early stage of only just turning to profit, so rather than declaring it overvalued on a single number, the fitting view is to keep checking whether the ₩50 billion revenue target and 1 million orders this year actually translate into profit.
- In short, demand and orders are strong, and the crux is how fast they harden into profit past the thin margin and heavy R&D.
🔎 Valuation vs peers Inconclusive
Compared against listed domestic robot and robot-component companies with close business characteristics and in a growth phase. Note that most of them are loss-making, so no P/E forms and the absolute figures are for reference only.
| Peer | P/E | P/B | ROE |
|---|---|---|---|
| Yujin Robot | — | 15.88x | -24.32% |
| Robostar | — | 7.64x | -5.99% |
| T-Robotics | — | 5.14x | -85.18% |
As shown by the fact that the peers Yujin Robot, Robostar, and T-Robotics are mostly loss-making so no P/E forms at all, this sector is early in its growth and is hard to line up by an earnings-based value (P/E). Robotis's P/E of 726x is also a figure derived by dividing the small profit of the first year in the black, so it is hard to cite as grounds for calling it overvalued, and in an earnings-inflection phase trailing metrics are overstated. If anything, its near-net-cash balance sheet, turn to profit, and humanoid demand are strengths ahead of the peer group. That said, the core margin is still thin, and how much of this year's ₩50 billion revenue plan hardens into profit needs further confirmation. For these reasons, rather than sorting overvalued or undervalued by a single trailing metric, 'inconclusive' is the accurate read.
Earnings outlook company-stated · verified
| Type | Period | Revenue | Operating profit | Net profit |
|---|---|---|---|---|
| This year | 2026 | approx. ₩50.0 billion | — | — |
Price history Close · MA20 · MA60
The latest close is ₩204,000 and the market capitalization is ₩3.0 trillion. The price sits below its 20-day moving average (₩260,695) and below its 60-day moving average (₩292,207). It is under both its short- and medium-term moving averages, so the trend looks subdued. The RSI (a supplementary indicator that gauges the strength of gains versus losses over the past 14 days on a 0-100 scale) is 34.8, a neutral level. The one-month change is -25.7%, the three-month change is -12.4%, and the position relative to the 52-week high is -49.6%. Relative strength versus the KOSDAQ is 89 (on a 1-99 scale, converted from returns against the index over the past year with more weight on recent performance; higher means stronger than the market). It is stronger than roughly 90% of all stocks. Over the past three months it outpaced the index by 9.4%. Chart interpretation is best done alongside trading volume and the dates on which disclosures occur.
Relative performance stock vs index · start = 100
Excess return vs index · 3M +9.38% / 6M -1.36% / 12M +200.63%
Key metrics vs sector median
Valuation
The P/E of 589.25x is above the sector median (29.49x). The P/B of 9.56x is above the sector median (6.92x).
Enterprise value (EV)
EV = market cap + net debt. It reflects cash and debt, so it captures the real cost of the whole business that market cap alone misses; lower multiples are cheaper relative to earnings or sales.
Profitability & financials
The operating margin is 8.6%. The debt ratio is 102.2%, so the financial structure is moderate.
Growth FY2025 · annual report (consolidated)
| Item | 2023 | 2024 | 2025 | YoY |
|---|---|---|---|---|
| Revenue | $19.3M | $19.9M | $25.8M | +29.64% ↑ faster |
| Operating profit | -$3.5M | -$2.0M | $2.2M | — |
| Net profit | -$895,633 | -$2.1M | $3.4M | — |
| 5-year | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $14.8M | $17.1M | $19.3M | $19.9M | $25.8M |
| Operating profit | -$615,696 | -$1.4M | -$3.5M | -$2.0M | $2.2M |
| Net profit | $481,726 | -$172,033 | -$895,633 | -$2.1M | $3.4M |
| Revenue CAGR | 4-yr avg 14.88% | ||||
Revenue rose 29.6% year over year (2023 ₩29.1 billion → 2024 ₩30.0 billion → 2025 ₩38.9 billion), and the three-year trend is 'rising'. The pace of growth also quickened from the prior year. Over the 5 years on record, revenue compound annual growth (CAGR) is 14.9%. The two-year revenue CAGR is 15.6%. In the most recent quarter (Q1 2026), revenue was 15.8% higher than the same period a year earlier.
Latest quarterly results Q1 2026 · vs year-ago
Technical indicators
What stands out
- Revenue grew 29.6% year over year, a sign of growth.
Points to watch
- The price is high versus peers, so expectations already appear priced in.
Recent news & events searched · sourced
- 2026-06-01FilingThe loss-making autonomous indoor-delivery robot business was spun off into a new wholly owned subsidiary (spin-off date June 1). The parent concentrates on the profitable actuator business.Medium term: positive for reinforcing the profit trend as an R&D loss source is separated out of the parent. However, the autonomous new business is transferred to the subsidiary and thus separated from the parent's growth axis. Source
- 2026-05-15EarningsFirst-quarter 2026 revenue of ₩11.84 billion (+15.8% year over year), operating loss of ₩11.84 billion. A non-recurring, non-cash factor as about ₩11.8 billion of treasury shares granted for executive/staff performance rewards in January was booked at once in SG&A.Short term: the surface loss is a non-recurring accounting effect; stripped out, the core is roughly around breakeven. Source
- 2026-05-12UpdateThe Korea Exchange ran procedures to pre-designate the stock as an investment-warning name and to designate it as an investment-caution name, citing excessive excess price gain over the past year.Short term: a market caution signal about the speed of the price surge rather than results, a factor for near-term volatility. Source
- 2026-04-06FilingReport of a change in large holdings related to the treasury-share performance grant. Background to the executive/staff performance grant being booked as first-quarter expense.Short term: a non-recurring effect on share count and expense recognition. A non-recurring item. Source
- 2026-03-16Earnings2025 annual report filed. Annual revenue of ₩38.9 billion (+29.6%), operating profit of ₩3.35 billion, and net profit of ₩5.07 billion, an annual turn to profit.Medium term: a document confirming revenue growth and a turn to profit after long losses, a reference point for the growth trend. Source
Figure cross-check computed ↔ external
| Metric | Computed | External | Status | Source |
|---|---|---|---|---|
| 2025 annual revenue | ₩38.9 billion(+29.6%) | ₩38.9 billion | Confirmed | link |
| First-quarter 2026 operating result | -₩11.8 billion | -₩11.8 billion | Confirmed | link |
| Core business (revenue mix) | (approx. 98%) | revenue 98% , X approx. 90% | Confirmed | link |
| 2026 revenue target | approx. ₩50.0 billion | — | Unverified | link |
Recent filings
- 2026-06-05OwnershipOfficers'/major-shareholders' holdings report
- 2026-05-15PeriodicQuarterly report
- 2026-05-04OwnershipOfficers'/major-shareholders' holdings report
- 2026-04-09OwnershipOfficers'/major-shareholders' holdings report
- 2026-04-06OwnershipOwnership-change filing
- 2026-03-24Shareholders' meeting notice
- 2026-03-16PeriodicAnnual business report
- 2026-03-16Audit report
- 2026-03-06Amended filing
- 2026-03-06Disclosure
- 2026-03-06Shareholders' meeting notice
- 2026-03-04Shareholders' meeting notice
📖 Plain-language glossary — expand if you are new to this
- P/E
- How many times a year's net profit the price is worth (lower is cheaper relative to earnings). The P/E here is on trailing (last full-year) results; for companies whose earnings swing fast (memory chips and other cyclicals/high-growth), a forward P/E on this year's expected earnings is more accurate.
- P/B
- Price relative to net assets (equity). Around 1x means it trades near book value; below 1x means below book.
- P/S
- Price relative to a year's revenue — useful for growth companies with thin earnings.
- Net debt / EV
- Net debt = interest-bearing debt − cash. Negative means more cash than debt (net cash). EV (enterprise value) = market cap + net debt, closer to what it would cost to buy the whole business.
- EV/EBIT · EV/EBITDA · EV/Sales
- Enterprise value against operating profit (EBIT), EBITDA, or revenue. Unlike P/E these reflect debt and cash; lower is cheaper relative to earnings power or sales.
- FCF / FCF yield
- Free cash flow = operating cash − capex, the cash actually left over. FCF yield = FCF ÷ market cap; higher means more cash generated per unit of market value.
- Intrinsic value (DCF)
- Future free cash flow (or, for some capex-heavy but profitable names, forecast earnings) discounted to today to estimate per-share value. Because it shifts a lot with the discount-rate and growth assumptions, it is shown as a bear/base/bull range, and the basis and assumptions are disclosed in one line beneath it.
- ROE
- How much profit the company earns in a year on its equity (%). Higher means better returns on capital.
- EPS / BPS
- Earnings per share / net assets (book value) per share.
- Operating / net margin
- Profit left from the core business / final profit after tax and interest, per unit of revenue.
- Debt ratio
- Debt relative to equity (%). Higher means more reliance on borrowing (norms vary by sector).
- Current ratio
- Assets convertible to cash within a year against debt due within a year. Above 100% leaves some short-term headroom.
- Interest coverage
- How many times operating profit covers the interest owed. Below 1x means operating profit alone struggles to cover interest.
- Dividend yield / payout ratio
- The year's dividend as a % of today's price / the share of earnings paid out as dividends.
- Revenue CAGR
- Multi-year growth expressed as a single yearly average (compound annual growth rate).
- RSI (short-term signal)
- Whether recent price action is overheated or beaten down. Above 70 is overbought, below 30 oversold.
- MA20 / MA60 (moving averages)
- The 20- and 60-day average price. Price above them signals a firmer short-term trend.
- vs 52-week high
- How far below the past year's peak the price sits now (%).
All figures are for reference only; how they read varies by sector and over time.
Sources: Korea FSC market-price API (data.go.kr), OpenDART, KRX/KIND — public data only.
Bong Stocks presents public-data-based information for reference only. It is not investment advice and contains no target prices, ratings, or buy/sell recommendations. Verify independently before making any decision.